Cargando…

Multiplexed Immunohistochemistry for Molecular and Immune Profiling in Lung Cancer—Just About Ready for Prime-Time?

As targeted molecular therapies and immuno-oncology have become pivotal in the management of patients with lung cancer, the essential requirement for high throughput analyses and clinical validation of biomarkers has become even more intense, with response rates maintained in the 20%–30% range. More...

Descripción completa

Detalles Bibliográficos
Autores principales:	Hofman, Paul, Badoual, Cécile, Henderson, Fiona, Berland, Léa, Hamila, Marame, Long-Mira, Elodie, Lassalle, Sandra, Roussel, Hélène, Hofman, Véronique, Tartour, Eric, Ilié, Marius
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	MDPI 2019
Materias:	Review
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6468415/ https://www.ncbi.nlm.nih.gov/pubmed/30818873 http://dx.doi.org/10.3390/cancers11030283

Ejemplares similares

A Real-World Experience from a Single Center (LPCE, Nice, France) Highlights the Urgent Need to Abandon Immunohistochemistry for ROS1 Rearrangement Screening of Advanced Non-Squamous Non-Small Cell Lung Cancer
por: Hofman, Véronique, et al.
Publicado: (2023)

Any Place for Immunohistochemistry within the Predictive Biomarkers of Treatment in Lung Cancer Patients?
por: Hofman, Véronique, et al.
Publicado: (2018)

Chromogenic Multiplex Immunohistochemistry Reveals Modulation of the Immune Microenvironment Associated with Survival in Elderly Patients with Lung Adenocarcinoma
por: Ilié, Marius, et al.
Publicado: (2018)

Association of TRF2 expression and myeloid-derived suppressor cells infiltration with clinical outcome of patients with cutaneous melanoma
por: Ilié, Marius, et al.
Publicado: (2021)

Deep Learning Facilitates Distinguishing Histologic Subtypes of Pulmonary Neuroendocrine Tumors on Digital Whole-Slide Images
por: Ilié, Marius, et al.
Publicado: (2022)

Nanobodies for Medical Imaging: About Ready for Prime Time?
por: Berland, Léa, et al.
Publicado: (2021)

Use of the 22C3 anti–PD-L1 antibody to determine PD-L1 expression in multiple automated immunohistochemistry platforms
por: Ilie, Marius, et al.
Publicado: (2017)

Correction: Use of the 22C3 anti-PD-L1 antibody to determine PD-L1 expression in multiple automated immunohistochemistry platforms
por: Ilie, Marius, et al.
Publicado: (2017)

Immunohistochemistry for Diagnosis of Metastatic Carcinomas of Unknown Primary Site
por: Selves, Janick, et al.
Publicado: (2018)

Detection of EGFR Mutations From Plasma of NSCLC Patients Using an Automatic Cartridge-Based PCR System
por: Heeke, Simon, et al.
Publicado: (2021)

“Sentinel” Circulating Tumor Cells Allow Early Diagnosis of Lung Cancer in Patients with Chronic Obstructive Pulmonary Disease
por: Ilie, Marius, et al.
Publicado: (2014)

Que reste t-il de la microscopie électronique pour le diagnostic anatomopathologique en 2010 ?
por: Mari, Mireille, et al.
Publicado: (2010)

Comparison of Two Rapid Assays for the Detection of BRAF V600 Mutations in Metastatic Melanoma including Positive Sentinel Lymph Nodes
por: Long-Mira, Elodie, et al.
Publicado: (2022)

Setting Up an Ultra-Fast Next-Generation Sequencing Approach as Reflex Testing at Diagnosis of Non-Squamous Non-Small Cell Lung Cancer; Experience of a Single Center (LPCE, Nice, France)
por: Ilié, Marius, et al.
Publicado: (2022)

An allogeneic NK cell line engineered to express chimeric antigen receptors: A novel strategy of cellular immunotherapy against cancer
por: Badoual, Cécile, et al.
Publicado: (2013)

Circulating Tumor Cell Detection in Lung Cancer: But to What End?
por: Hofman, Véronique, et al.
Publicado: (2019)

Setting up a wide panel of patient-derived tumor xenografts of non–small cell lung cancer by improving the preanalytical steps
por: Ilie, Marius, et al.
Publicado: (2015)

Identification of a circulating immunological signature predictive of response to immune checkpoint inhibitors in patients with advanced non‐small cell lung cancer
por: Khatir, Wassila, et al.
Publicado: (2022)

Daily Practice Assessment of KRAS Status in NSCLC Patients: A New Challenge for the Thoracic Pathologist Is Right around the Corner
por: Bontoux, Christophe, et al.
Publicado: (2022)

Optimization of EGFR mutation detection by the fully-automated qPCR-based Idylla system on tumor tissue from patients with non-small cell lung cancer
por: Ilie, Marius, et al.
Publicado: (2017)

Brightfield multiplex immunohistochemistry with multispectral imaging
por: Morrison, Larry E., et al.
Publicado: (2020)

Evaluation of Sample Pooling for SARS-CoV-2 Detection in Nasopharyngeal Swab and Saliva Samples with the Idylla SARS-CoV-2 Test
por: Hofman, Paul, et al.
Publicado: (2021)

Diagnostic histologique des infections bactériennes nécrosantes extensives du poumon: Étude de 4 observations d’évolution fulminante
por: Lassalle, Sandra, et al.
Publicado: (2005)

Multiplex immunohistochemistry accurately defines the immune context of metastatic melanoma
por: Halse, H., et al.
Publicado: (2018)

Accurate Detection of SARS-CoV-2 by Next-Generation Sequencing in Low Viral Load Specimens
por: Ilié, Marius, et al.
Publicado: (2023)

Use of the Ion PGM and the GeneReader NGS Systems in Daily Routine Practice for Advanced Lung Adenocarcinoma Patients: A Practical Point of View Reporting a Comparative Study and Assessment of 90 Patients
por: Heeke, Simon, et al.
Publicado: (2018)

Targeted Assessment of the EGFR Status as Reflex Testing in Treatment-Naive Non-Squamous Cell Lung Carcinoma Patients: A Single Laboratory Experience (LPCE, Nice, France)
por: Lassalle, Sandra, et al.
Publicado: (2020)

Expression of MET in circulating tumor cells correlates with expression in tumor tissue from advanced-stage lung cancer patients
por: Ilie, Marius, et al.
Publicado: (2017)

Perspectives and Issues in the Assessment of SMARCA4 Deficiency in the Management of Lung Cancer Patients
por: Armon, Subasri, et al.
Publicado: (2021)

REBOA: is it ready for prime time?
por: Doucet, Jay, et al.
Publicado: (2017)

Increased Angiogenesis and Lymphangiogenesis in Adenomyosis Visualized by Multiplex Immunohistochemistry
por: Harmsen, Marissa J., et al.
Publicado: (2022)

Molecular Profiling in Non-Squamous Non-Small Cell Lung Carcinoma: Towards a Switch to Next-Generation Sequencing Reflex Testing
por: Pujol, Nina, et al.
Publicado: (2022)

Biomarkers for Chronic Lung Allograft Dysfunction: Ready for Prime Time?
por: Verleden, Stijn E., et al.
Publicado: (2022)

Monitoring BRAF and NRAS mutations with cell-free circulating tumor DNA from metastatic melanoma patients
por: Long-Mira, Elodie, et al.
Publicado: (2018)

Is pocket ultrasound ready for prime time?
por: Galen, Benjamin T
Publicado: (2012)

Radiotherapy for HCC: Ready for prime time?
por: Bang, Andrew, et al.
Publicado: (2019)

Commentary: Almost ready for prime time
por: Wei, Lawrence M.
Publicado: (2020)

CGM in the Hospital: Is It Ready for Prime Time?
por: Buschur, Elizabeth O., et al.
Publicado: (2022)

Establishing a Dedicated Lung Cancer Biobank at the University Center Hospital of Nice (France). Why and How?
por: Washetine, Kevin, et al.
Publicado: (2018)

The Need to Set up a Biobank Dedicated to Lymphoid Malignancies: Experience of a Single Center (Laboratory of Clinical and Experimental Pathology, University Côte d’Azur, Nice, France)
por: Bontoux, Christophe, et al.
Publicado: (2023)

Cannot write session to /tmp/vufind_sessions/sess_o12f6d9p6i8ps994v8tr7jalkv